WORLD MEDICINE LIMITEDActive
Key figures
Like most small UK companies, WORLD MEDICINE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £177,280.
Filed accounts2020–2025
| 2020 | 2021 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Turnover | 3,051,885 | — | — | — | — |
| Profit for the year | 20,611 | — | — | — | — |
| Cash at bank and in hand | 106,694 | 93,199 | 47,054 | 172,781 | 36,383 |
| Total assets | 1,321,672 | 1,432,152 | 762,388 | 663,775 | 534,834 |
| Total liabilities | 691,443 | 760,290 | 679,165 | — | 486,046 |
| Net assets / total equity | 630,229 | 671,862 | 83,223 | 116,459 | 148,788 |
| Average number of employees | 5 | 5 | 5 | 0 | 0 |
| Dividends paid | 177,280 | — | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: WORLD MEDICINE LIMITED
Company
WORLD MEDICINE LIMITED is a private limited company registered with Companies House under company number 05285277. It was incorporated on 12 Nov 2004. Its status is active. The registered office is in London (N3). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200), wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Net assets were £148,788, up 27.8% on the previous year. Cash at bank and in hand was £36,383. Total assets were £534,834 and total liabilities £486,046. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2025).
Control and charges
The company has 1 current director. One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 7 Jul 2027.